| Volume reduction in routine cord blood banking. | |
| | |
MedLine Citation:
|
PMID: 20528760 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Umbilical cord blood (UCB) is an alternative source of hematopoietic progenitors for transplantation in the treatment of haematological malignancies, marrow failure, immunodeficiencies, hemoglobinopathies and inherited metabolic diseases. It has greatly contributed to increase the feasibility to transplantation for many patients in need. To date, more than 20,000 UCB transplants have been performed on children and adults, and more than 400,000 UCB units are available in more than 50 public CB banks. One of the most important objectives of banks is to cryopreserve and store high quality UCB units. Volume reduction is a usual process in cord blood banking that has some advantages as reducing the storage space and the DMSO quantity in final product. Volume reduction methodology must guarantee high cell recovery and red blood cell (RBC) depletion by reducing the UCB units to a standard volume. Hydroxyethyl starch (HES) sedimentation was the first method developed for this purpose by the New York Cord Blood Bank and implemented in many banks worldwide. The semi-automated top and bottom system, usually used for blood fractionation was further developed to simplify and short the process. Later, automatic devices as SEPAX and AXP have been developed in last years specifically for UCB volume reduction purpose. This review critically analyses the advantages and disadvantages of the different procedures. All of them have been used in Valencia Cord Blood Bank along 10 years. In general, automatic devices are preferred because of compliance with cGTP, closed systems, higher reproducibility and less influence of technician. |
| | |
Authors:
|
Pilar Solves; Vicente Mirabet; Roberto Roig |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Current stem cell research & therapy Volume: 5 ISSN: 1574-888X ISO Abbreviation: Curr Stem Cell Res Ther Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2010-11-01 Completed Date: 2011-06-01 Revised Date: 2012-01-19 |
Medline Journal Info:
|
Nlm Unique ID: 101272517 Medline TA: Curr Stem Cell Res Ther Country: United Arab Emirates |
Other Details:
|
Languages: eng Pagination: 362-6 Citation Subset: IM |
Affiliation:
|
Umbilical Cord Blood Bank, Transfusion Centre.Valencia, Spain. solves_pil@gva.es |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Automation, Laboratory Blood Banks Cell Fractionation / methods Fetal Blood / cytology Hematologic Neoplasms / pathology, therapy* Hematopoietic Stem Cell Transplantation* Hematopoietic Stem Cells / cytology, metabolism* Humans Immunologic Deficiency Syndromes / pathology, therapy* Metabolic Diseases / genetics, pathology, therapy* Stem Cell Niche |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The impact of molecularly targeted therapies upon the understanding of leukemogenesis and the role o...
Next Document: In vitro haematopoiesis of a novel dendritic-like cell present in murine spleen.